The document summarizes the structure and function of various parts of the central nervous system (CNS), including the brain and spinal cord. It describes the roles of key regions like the cerebrum, basal ganglia, diencephalon, brainstem, cerebellum, and limbic system. It also discusses the unique blood-brain barrier, chemical synapses, and major neurotransmitters in the CNS such as acetylcholine, monoamines, GABA, and amino acids. The spinal cord's gray and white matter and role in pain transmission are briefly covered as well.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
42 views
5) General Principles of Central
The document summarizes the structure and function of various parts of the central nervous system (CNS), including the brain and spinal cord. It describes the roles of key regions like the cerebrum, basal ganglia, diencephalon, brainstem, cerebellum, and limbic system. It also discusses the unique blood-brain barrier, chemical synapses, and major neurotransmitters in the CNS such as acetylcholine, monoamines, GABA, and amino acids. The spinal cord's gray and white matter and role in pain transmission are briefly covered as well.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 30
Dr.
Mehwish Waseem DPT, MS-CPPT • The CNS:brain and spinal cord
• Cerebrum: largest ,bilateral hemisphere…several lobes (frontal,
temporal, parietal, and occipital). The outer cerebrum, or cerebral cortex, is the highest order of conscious function and integration in the CNS…sensory and motor functions as well as intellectual and cognitive abilities. ..short-term memory and speech. • supervisory capacity regarding lower brain functioning and may influence the control of other activities such as the autonomic nervous system. • CNS drugs…tend to affect cortical function indirectly by first altering the function of lower brain and spinal cord structures. • An exception is the group of drugs used to treat epilepsy; these drugs are often targeted directly for hyperexcitable neurons in the cerebral cortex. • In addition, drugs that attempt to enhance cognitive function in conditions such as Alzheimer disease might also exert their primary effects in the cerebrum. located deep within the cerebral hemispheres caudate nucleus, putamen, globus pallidus,
lentiform nucleus, and substantia nigra.
control of motor activities; deficits in this area
are significant in movement disorders such as
Parkinson disease. The area of the brain enclosing the third ventricle is the diencephalon…thalamus and hypothalamus. The thalamus contains distinct nuclei that are
crucial in the integration of certain types of
sensations and their relay to other areas of the brain (such as the somatosensory cortex). The hypothalamus is involved in the control of
diverse body functions including temperature
control, appetite, water balance, and certain emotional reactions…control over the function of hormonal release from the pituitary gland. • a bridge between the higher areas of the brain (cerebrum and diencephalon) and the brainstem. • Brainstem: pons and the medulla oblongata. • locations of centers responsible for controlling respiration and cardiovascular function (vasomotor center). • The reticular formation is also located in the midbrain and brainstem. ..collection of neurons that extend from the reticular substance of the upper spinal cord through the midbrain and the thalamus. • regulating the amount of arousal or alertness in the cerebral cortex. • CNS drugs that affect the arousal state of the individual tend to exert their effects on the reticular formation… Sedative-hypnotics and general anesthetics…CNS stimulants (caffeine, amphetamines) • lies posterior to the brainstem and is separated from it by the fourth ventricle. • … two hemispheres…three lobes (anterior, posterior, and flocculonodular). • Plan and coordinate motor activity • Concerned with the vestibular mechanisms responsible for maintaining balance and posture. • Therapeutic medications are not usually targeted directly for the cerebellum, but incoordination and other movement disorders may result if a drug exerts a toxic side effect on the cerebellum. • The limbic system is comprised of several structures that are dispersed throughout the brain but are often considered as a functional unit or system within the CNS. • Major components of the limbic system include cortical structures (such as the amygdala, hippocampus, and cingulate gyrus), the hypothalamus, certain thalamic nuclei, mamillary bodies, septum pellucidum, and several other structures and tracts. • control of emotional and behavioral activity. • Certain aspects of motivation, aggression… • CNS drugs affecting these aspects of behavior, including some antianxiety and antipsychotic medications, are believed to exert their beneficial effects primarily by altering activity in the limbic structures. • The spinal cord is cylindrically shaped and consists of centrally located gray matter that is surrounded by white matter. • The gray matter serves as an area for synaptic connections between various neurons. • The white matter consists of the myelinated axons of neurons, which are grouped into tracts ascending or descending between the brain and specific levels of the cord. • Certain CNS drugs exert some or all of their effects by modifying synaptic transmission in specific areas of gray matter, while other CNS drugs, such as narcotic analgesics, may exert an effect on synaptic transmission in the gray matter of the cord as well as on synapses in other areas of the brain. • Some drugs may be specifically directed toward the white matter of the cord. • Drugs such as local anesthetics can be used to block action potential propagation in the white matter so that ascending or descending information is interrupted (i.e., a spinal block unique structure and function of CNS capillaries. Certain substances are not able to pass from the
bloodstream into the CNS, despite the fact that
these substances are able to pass from the systemic circulation into other peripheral tissues. caused primarily by the tight junctions that occur
between capillary endothelial cells; in fact, CNS
capillaries lack the gaps and fenestrations that are seen in peripheral capillaries. as a selective filter and seems to protect the CNS • drugs targeted for the CNS must be able to pass from the bloodstream into the brain and spinal cord. • In general, nonpolar, lipid-soluble drugs are able to cross the blood-brain barrier by passive diffusion. • Polar and lipophobic compounds are usually unable to enter the brain. Some exceptions occur because of the presence of carrier-mediated transport systems in the blood-brain barrier…(such as glucose) are transported via facilitated diffusion, while other compounds (including some drugs) may be able to enter the brain by active transport. • the typical manner by which most drugs enter the brain is by passive lipid diffusion. The majority of neural connections in the human brain and spinal cord are characterized as chemical synapses The chemical synapse indicates that a chemical
neurotransmitter is used to propagate the nervous
impulse across the gap that exists between two neurons. excitation or inhibition of the other neurons. • found in many areas of the brain as well as in the periphery (skeletal neuromuscular junction, some autonomic synapses). • In the brain, acetylcholine is abundant in the cerebral cortex, and seems to play a critical role in cognition and memory. • Neurons originating in the large pyramidal cells of the motor cortex and many neurons originating in the basal ganglia also secrete acetylcholine from their terminal axons. • In general, acetylcholine synapses in the CNS are excitatory in nature. Monoamines are a group of structurally similar CNS neurotransmitters that include the catecholamines (dopamine, norepinephrine) and 5-hydroxytryptamine (serotonin). • Dopamine exerts different effects at various locations within the brain. • Within the basal ganglia, dopamine is secreted by neurons that originate in the substantia nigra and project to the corpus striatum. As such, it is important in regulating motor control, and the loss of these dopaminergic neurons results in symptoms commonly associated with Parkinson disease • Dopamine also influences mood and emotions, primarily via its presence in the hypothalamus and other structures within the limbic system. Although its effects within the brain are very complex, dopamine generally inhibits the neurons onto which it is released. is secreted by neurons that originate in the locus caeruleus of the pons and projects throughout the reticular formation. generally as an inhibitory transmitter within the
CNS, but the overall effect following activity of
norepinephrine synapses is often general excitation of the brain, probably because norepinephrine directly inhibits other neurons that produce inhibition. This phenomenon of disinhibition causes excitation by removing the influence of inhibitory neurons. is released by cells originating in the midline of the pons and brainstem and is projected to many different areas, including the dorsal horns of the spinal cord and the hypothalamus. strong inhibitor (painfull stimuli) Involved in controlling many aspects of mood and
behavior, and problems with serotonergic activity
have been implicated in several psychiatric disorders, including depression and anxiety. glycine and gammaaminobutyric acid (GABA) Inhibitory transmitters…at presynaptic and
postsynaptic neurons in the brain and spinal cord.
Other amino acids such as aspartate and glutamate
have been found in high concentrations
throughout the brain and spinal cord; these substances cause excitation of CNS neurons. These excitatory amino acids have received a great
deal of attention lately because they may also
produce neurotoxic effects when released in large amounts during CNS injury and certain neurologic disorders (epilepsy, amyotrophic lateral sclerosis, and so forth). substance P…excitatory transmitter that is involved in spinal cord pathways transmitting pain impulses. Increased activity at substance P synapses in the
cord serves to mediate the transmission of painful
sensations, and certain drugs such as the opioid analgesics may decrease activity at these synapses. endorphins, enkephalins, and dynorphins…
endogenous opioids…inhibit painful
sensations. ..decrease the central perception of pain. Recent evidence has implicated substances such as adenosine and adenosine triphosphate (ATP) as transmitters or modulators of neural transmission in specific areas of the brain and in the autonomic nervous system. CNS drugs increase or decrease transmission at specific synapses. psychotic behavior…overactivity dopamine as a
neurotransmitter . Drug therapy…decrease activity
at central dopamine synapses. Parkinson disease…decrease in dopamine
synapses… Antiparkinsonian drugs attempt to
increase dopaminergic transmission . AP… at the presynaptic terminal…neurotransmitter release. local anesthetics, block propagation along neural
axons so that the action potential fails to reach the
presynaptic terminal. the amount of depolarization or the height of the
action potential arriving at the presynaptic terminal
is directly related to the amount of transmitter released… presynaptic inhibition,…GABA is believed to exert some of its inhibitory effects via this mechanism. metyrosine (Demser).. inhibits an enzyme that is essential for catecholamine biosynthesis in the presynaptic terminal. Treatment with metyrosine results in decreased
synthesis of transmitters such as dopamine and
norepinephrine. A certain amount of chemical transmitter is stored in presynaptic vesicles. Drugs that impair this storage will decrease the ability of the synapse to continue to transmit information for extended periods. antihypertensive drug reserpine , which impairs the
ability of adrenergic terminals to sequester and
store norepinephrine in presynaptic vesicles. Certain drugs will increase synaptic activity by directly increasing the release of neurotransmitter from the presynaptic terminal. Amphetamines…increasing the presynaptic release
of catecholamine neurotransmitters Conversely, botulinum toxin (Botox)…impair the
release of acetylcholine from the skeletal
neuromuscular junction. movement of the transmitter molecule back into the presynaptic terminal. A drug that impairs the reuptake of transmitter
allows more of it to remain in the synaptic cleft and
continue to exert an effect…tricyclic antidepressants impair the reuptake mechanism that pumps amine neurotransmitters back into the presynaptic terminal, which allows the transmitter to continue to exert its effect and prolong activity at the synapse. Cholinesterase …myasthenia gravis… functional decrease in activity at the skeletal neuromuscular junction. Anticholinesterase drugs such as neostigmine and
pyridostigmine inhibit acetylcholine breakdown,
allowing more of the released neurotransmitter to continue to exert an effect at the neuromuscular synapse. chemical antagonists… block the postsynaptic receptor, thus decreasing synaptic transmission. use of beta blocker..beta-adrenergic receptors on
the myocardium, and they are frequently used to
treat hypertension, cardiac arrhythmias, and angina pectoris. Other drugs may improve synaptic transmission…
improved receptor–effector coupling,…
benzodiazepines (e.g., diazepam [Valium],appear to enhance the postsynaptic
effects of the inhibitory neurotransmitter GABA.
receptors on the presynaptic terminal of some types of chemical synapses…negative feedback in controlling neurotransmitter release. clonidine (Catapres), may exert some of its
antihypertensive effects by binding to presynaptic
receptors on sympathetic postganglionic neurons and impairing the release of norepinephrine onto the peripheral vasculature. Drugs may alter synaptic transmission by affecting membrane organization and fluidity(amount of flexibility/mobility of lipid bilayer). Alcohol(ethanol) or general anaesthetics.
No Matter Never Mind Proceedings of Toward a Science of Consciousness Fundamental approaches Tokyo 1999 1st Edition Kunio Yasue - Download the ebook now for an unlimited reading experience
Where can buy (Ebook) Reading EEGs: A Practical Approach, 2nd Edition by L. John Greenfield Jr., Paul R. Carney, James D. Geyer ISBN 9781975121198, 1975121198, 2020011061 ebook with cheap price